Allianz Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Allianz Asset Management's IART Position: Q3 2026 in Review
Allianz Asset Management increased its Integra LifeSciences (IART) stake by 6.9% in Q3 2026, buying an estimated $1.19M and bringing the position to 1,074,363 shares worth $17.5M. The position accounts for 0.02% of the portfolio, ranked #700.
Allianz Asset Management first reported a position in IART in Q3 2016 and has held it in 17 quarters since. The position peaked at $18.1M in Q2 2026. 233 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Allianz Asset Management held 1,074,363 shares of Integra LifeSciences worth $17.5M as of Q3 2026.
- Allianz Asset Management bought 69,160 Integra LifeSciences shares in Q3 2026, an estimated $1.19M.
- Integra LifeSciences made up 0.02% of Allianz Asset Management's portfolio in Q3 2026, its #700 holding.
- Allianz Asset Management first reported a position in Integra LifeSciences in Q3 2016 and has held it in 17 quarters since.
- Allianz Asset Management's Integra LifeSciences position peaked at $18.1M in Q2 2026.
- 233 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Allianz Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.